A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivoJianling Zou(Shanghai Jiao Tong University), Lin Shen(Peking University)Cell Death and DiseaseMay 31, 201810.1038/s41419-018-0700-0Cited by 53SaveCiteExport RISWatch citationsRelated PapersZolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial|Nature Medicine|2023|541